188 related articles for article (PubMed ID: 1519431)
21. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
Kato K; Yoshida N; Matsumoto K; Matsuyama T
Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
[TBL] [Abstract][Full Text] [Related]
22. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
[No Abstract] [Full Text] [Related]
24. ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse.
Giona F; Testi AM; Rondelli R; Amadori S; Arcese W; Meloni G; Moleti ML; Ceci A; Pillon M; Madon E; Comis M; Pession A; Mandelli F
Br J Haematol; 1997 Dec; 99(3):671-7. PubMed ID: 9401083
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
Matsuyama T; Kojima S; Kato K
Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
[TBL] [Abstract][Full Text] [Related]
26. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: first Dutch prospective study.
Löwenberg B; van Putten WL; Verdonck LF; Dekker AW; de Gast GC; Willemze R; Zwaan FE; Abels J; Sonneveld P; van der Lelie J
Haematol Blood Transfus; 1990; 33():655-60. PubMed ID: 2182456
[TBL] [Abstract][Full Text] [Related]
27. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
[TBL] [Abstract][Full Text] [Related]
28. Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Mughal T; Morleda J; Goldman J
Acta Haematol; 1993; 89(3):149-51. PubMed ID: 8362603
[TBL] [Abstract][Full Text] [Related]
29. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.
Sebban C; Lepage E; Vernant JP; Gluckman E; Attal M; Reiffers J; Sutton L; Racadot E; Michallet M; Maraninchi D
J Clin Oncol; 1994 Dec; 12(12):2580-7. PubMed ID: 7989932
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
[TBL] [Abstract][Full Text] [Related]
32. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.
Vey N; Blaise D; Stoppa AM; Bouabdallah R; Lafage M; Sainty D; Cowen D; Viens P; Lepeu G; Blanc AP
Bone Marrow Transplant; 1994 Sep; 14(3):383-8. PubMed ID: 7994259
[TBL] [Abstract][Full Text] [Related]
34. [Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the coordinating center's results].
Parovichnikova EN; Troitskaia VV; Kliasova GA; Kuz'mina LA; Sokolov AN; Paramonova EV; Galstian GM; Kessel'man SA; Drokov MIu; Vasil'eva VA; Obukhova TN; Kulikov SM; Savchenko VG
Ter Arkh; 2014; 86(7):14-23. PubMed ID: 25314773
[TBL] [Abstract][Full Text] [Related]
35. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
[TBL] [Abstract][Full Text] [Related]
36. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
[TBL] [Abstract][Full Text] [Related]
37. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
Lawson SE; Harrison G; Richards S; Oakhill A; Stevens R; Eden OB; Darbyshire PJ
Br J Haematol; 2000 Mar; 108(3):531-43. PubMed ID: 10759711
[TBL] [Abstract][Full Text] [Related]
38. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.
Hoogerbrugge PM; Gerritsen EJ; vd Does-van den Berg A; vd Berg H; Zwinderman AH; Hermans J; Vossen JM
Bone Marrow Transplant; 1995 Feb; 15(2):255-9. PubMed ID: 7773215
[TBL] [Abstract][Full Text] [Related]
39. Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
Arcese W; Meloni G; Giona F; Vegna ML; Testi AM; Annino L; Iori AP; Carotenuto M; Resegotti L; Madon E
Bone Marrow Transplant; 1991; 7 Suppl 2():38. PubMed ID: 1878711
[No Abstract] [Full Text] [Related]
40. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]